Analysts expect that National Health Investors Inc (NYSE:NHI) will post $74.22 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for National Health Investors’ earnings, with the highest sales estimate coming in at $74.55 million and the lowest estimate coming in at $73.86 million. National Health Investors reported sales of $71.35 million during the same quarter last year, which would suggest a positive year over year growth rate of 4%. The business is scheduled to issue its next earnings results before the market opens on Tuesday, November 6th.

According to Zacks, analysts expect that National Health Investors will report full year sales of $295.33 million for the current year, with estimates ranging from $294.20 million to $297.00 million. For the next year, analysts anticipate that the business will report sales of $313.02 million, with estimates ranging from $296.69 million to $322.41 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for National Health Investors.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 EPS for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.05). National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. The business had revenue of $72.96 million during the quarter, compared to analysts’ expectations of $73.80 million.

NHI has been the topic of a number of research reports. Wells Fargo & Co reissued a “hold” rating on shares of National Health Investors in a research note on Tuesday, August 28th. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research note on Wednesday, July 25th. Cantor Fitzgerald raised their target price on shares of National Health Investors from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, August 8th. SunTrust Banks reissued a “hold” rating and issued a $79.00 target price on shares of National Health Investors in a research note on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 target price on shares of National Health Investors and gave the company a “buy” rating in a research note on Tuesday, August 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $75.22.

Shares of NHI stock traded down $0.90 during mid-day trading on Friday, reaching $70.60. The company’s stock had a trading volume of 232,052 shares, compared to its average volume of 205,974. National Health Investors has a 12-month low of $62.71 and a 12-month high of $81.60. The company has a current ratio of 15.56, a quick ratio of 15.56 and a debt-to-equity ratio of 0.90. The company has a market cap of $3.19 billion, a PE ratio of 13.25, a P/E/G ratio of 3.26 and a beta of 0.34.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 9th. Investors of record on Friday, September 28th will be issued a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 5.67%. The ex-dividend date is Thursday, September 27th. National Health Investors’s payout ratio is 75.05%.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NHI. Campbell & CO Investment Adviser LLC grew its holdings in National Health Investors by 18.6% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 4,466 shares of the real estate investment trust’s stock worth $329,000 after acquiring an additional 700 shares in the last quarter. UBS Group AG grew its holdings in National Health Investors by 1.0% during the 1st quarter. UBS Group AG now owns 70,004 shares of the real estate investment trust’s stock worth $4,710,000 after acquiring an additional 714 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its holdings in National Health Investors by 12.3% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 6,986 shares of the real estate investment trust’s stock worth $515,000 after acquiring an additional 766 shares in the last quarter. Xact Kapitalforvaltning AB grew its holdings in National Health Investors by 15.5% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 5,951 shares of the real estate investment trust’s stock worth $438,000 after acquiring an additional 800 shares in the last quarter. Finally, Asset Management One Co. Ltd. grew its holdings in National Health Investors by 0.8% during the 1st quarter. Asset Management One Co. Ltd. now owns 110,634 shares of the real estate investment trust’s stock worth $7,445,000 after acquiring an additional 832 shares in the last quarter. 68.67% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Recommended Story: Book Value Per Share – BVPS

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.